CARE Ratings (BOM:534804) Altman Z2-Score: 12.48 (As of Aug. 08, 2026) — 11% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:534804 CARE Ratings Ltd BOM:534804
81 GF Score
Price ₹1,746.10
GF Value ₹1,709.11
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is CARE Ratings Altman Z2-Score?

CARE Ratings BOM:534804 +1.00% 81 Altman Z2-Score is 12.48 as of Aug. 08, 2026, which is 11% below its 10-year median of 13.95. GuruFocus rates BOM:534804 with a GF Score™ of 81/100 and a GF Value™ of ₹1,709.11 (Fairly Valued). The stock has 1 warning sign investors should review. Among 656 Capital Markets companies, CARE Ratings ranks better than 80.95% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

CARE Ratings has a Altman Z2-Score of 12.48, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for CARE Ratings's Altman Z2-Score or its related term are showing as below:

BOM:534804' s Altman Z2-Score Range Over the Past 10 Years
Min: 11.57   Med: 13.95   Max: 17.25
Current: 12.48

During the past 13 years, CARE Ratings's highest Altman Z2-Score was 17.25. The lowest was 11.57. And the median was 13.95.


CARE Ratings  (BOM:534804) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


CARE Ratings Altman Z2-Score Related Terms


CARE Ratings Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for CARE Ratings's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARE Ratings Altman Z2-Score Chart

CARE Ratings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.02 13.54 13.66 12.90 12.48

CARE Ratings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.90 0.00 10.91 0.00 12.48

BOM:534804 vs SPGI, CME, ICE: Altman Z2-Score Comparison

For the Financial Data & Stock Exchanges subindustry, CARE Ratings's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CARE Ratings Altman Z2-Score vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CARE Ratings's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where CARE Ratings's Altman Z2-Score falls into.


BOM:534804
81GF Score
CARE Ratings Ltd BOM:534804
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CARE Ratings Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

CARE Ratings's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.5066+3.26*0.5073+6.72*0.2153+1.05*5.7697
=12.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ₹11,047 Mil.
Total Current Assets was ₹6,773 Mil.
Total Current Liabilities was ₹1,177 Mil.
Retained Earnings was ₹5,604 Mil.
Pre-Tax Income was 720.087 + 489.938 + 769.109 + 374.399 = ₹2,354 Mil.
Interest Expense was -6.254 + -6.47 + -6.144 + -5.994 = ₹-25 Mil.
Total Liabilities was ₹1,616 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(6773.089 - 1176.833)/11047.37
=0.5066

X2=Retained Earnings/Total Assets
=5604.461/11047.37
=0.5073

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(2353.533 - -24.862)/11047.37
=0.2153

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(9324.452 - 0)/1616.119
=5.7697

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

CARE Ratings has a Altman Z2-Score of 12.48 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 12.48 mean?
CARE Ratings (BOM:534804) has a Altman Z2-Score of 12.48 as of Aug. 08, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on CARE Ratings and its competitors. This is 11% below median its historical median of 13.95. Over the past decade, CARE Ratings' Altman Z2-Score has ranged from 11.57 to 17.25. According to the industry distribution chart, CARE Ratings ranks #125 out of 656 companies in the Capital Markets industry, placing it in the top 19.1%.
Is CARE Ratings' Altman Z2-Score too high?
CARE Ratings' current Altman Z2-Score of 12.48 is 11% below median its 10-year median of 13.95. Over the past 10 years, this metric has ranged from a low of 11.57 to a high of 17.25. The Capital Markets industry median Altman Z2-Score is 4.13. CARE Ratings' value of 12.48 is 202.2% above this industry median. Based on the distribution chart, CARE Ratings ranks #125 out of 656 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, CARE Ratings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' Altman Z2-Score compare to SPGI and CME?
According to the Capital Markets industry distribution chart, CARE Ratings ranks #125 out of 656 companies for Altman Z2-Score. This places CARE Ratings in the top 19% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 4.13. CARE Ratings' value of 12.48 is 202.2% above this benchmark. Historically, CARE Ratings' own Altman Z2-Score has ranged from 11.57 to 17.25 over the past decade. While the company's 10-year median is 13.95 vs. the industry median of 4.13, CARE Ratings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Capital Markets company?
The median Altman Z2-Score among Capital Markets companies is 4.13, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CARE Ratings's current Altman Z2-Score of 12.48 is 202.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on CARE Ratings and its competitors. For the Capital Markets industry, the median Altman Z2-Score is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARE Ratings's current Altman Z2-Score is 12.48, which is 11% below median its own 10-year median of 13.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (BOM:534804) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,709.11, compared to a current price of ₹1,746.10 — trading 2.2% above its estimated fair value. The current Altman Z2-Score is 12.48, which is 11% below median its 10-year median of 13.95 and 202.2% above the Capital Markets industry median of 4.13. CARE Ratings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For CARE Ratings (BOM:534804), the current Altman Z2-Score is 12.48 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CARE Ratings (BOM:534804) Overvalued in 2026?

Based on GuruFocus' analysis, CARE Ratings stock appears to be overvalued. The current stock price of ₹1,746.10 is trading 2.2% above its estimated GF Value™ of ₹1,709.11. GuruFocus considers CARE Ratings to be Fairly Valued.

Key valuation signals for BOM:534804:

  • Altman Z2-Score: 12.48 (11% below median its 10-year median of 13.95)
  • GF Value™: ₹1,709.11 vs. price of ₹1,746.10 (2.2% above fair value)
  • GF Score™: 81/100 with 1 warning sign
  • Industry Position: 202.2% above the Capital Markets median (#125 of 656)

No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CARE Ratings Business Description

Other Exchanges CARERATING:India
Address Somaiya Hospital Road, Off Eastern Express Highway, 4th Floor, Godrej Coliseum, Sion (East), Mumbai, MH, IND, 400 022
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
81GF Score

Get the complete analysis for BOM:534804

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,746.10
Price
₹1,709.11
GF Value